Skip to Main Content

Paper Details

Correction to: Efficacy and safety of ixazomib plus lenalidomide and dexamethasone following injectable piâ¿¿based therapy in relapsed/refractory multiple myeloma.
Ann Hematol
0
2023
Author NameAffiliation
Hiroshi HandaGunma University Graduate School of Medicine
  • 1 - 1

Datasets

Release 1.2